3-Hydroxyphencyclidine (3-HPC), a breakdown product of phencyclidine (PCP), is ever more attracting clinical scrutiny due to limited data suggesting distinct biological properties. Current research indicate that 3-HPC may exhibit separate responses on the nervous nervous system, potentially contributing to some of the unexplained symptoms relate… Read More